Kenai Therapeutics

Kenai Therapeutics is a biotechnology company developing allogeneic neuron replacement cell therapies for neurological disorders using induced pluripotent stem cell (iPSC) technology. Their lead candidate, RNDP-001, targets Parkinson's disease and has shown promising results in preclinical models. The company aims to provide curative treatments for patients with limited treatment options.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $82M

Date: 29-Feb-2024

Investors: Alaska Permanent Fund Corporation, Cure Ventures, The Column Group, Euclidean Capital, Saisei Ventures

Markets: Biotechnology, Cell Therapy, Neurology, Drug Discovery

HQ: San Diego, California, United States

Founded: 2022

Website: https://www.kenaitx.com

LinkedIn: https://www.linkedin.com/company/kenaitx

Twitter:

Instagram: